Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • No selection...

    No selection process-ICMR, Pfizer collaboration on AMR project draws Objections from industry

    Meghna A SinghaniaWritten by Meghna A Singhania Published On 2019-02-15T13:06:57+05:30  |  Updated On 15 Feb 2019 1:06 PM IST
    No selection process-ICMR, Pfizer collaboration on AMR project draws Objections from industry
    Keeping a close watch, critics of this collaboration pointed out that training and educating health personnel under the AMR project would grant Pfizer access to policymakers besides the doctor.

    New Delhi: The joint decision of New York-based drugmaker Pfizer and Indian Council for Medical Research (ICMR) to collaborate for the council's Anti-Microbial Resistance (AMR) project seems to have ignited criticism with allegations that there was no selection procedure by which ICMR decided to partner with Pfizer from among dozens of Indian and multinational pharma companies that manufacture antibiotics.


    Recent reports in Times of India have elaborated in detail about the charges of conflict of interest.


    Critics pitched soon after the council collaborated with a multinational antibiotic seller, Pfizer for the AMR project,asking details of how the collaboration was made. The project proposes that the ICMR network hospitals would adopt nursing homes/ district hospitals in surrounding areas and provide training to the nursing homes and district hospitals in various aspects.


    Keeping a close watch, critics of this collaboration points out that training and educating health personnel under the AMR project would grant Pfizer access to policymakers besides the doctor.


    As per the TOI report, it will specifically helpful for the company given its recent declaration that it will stop sponsoring and gifting doctors. Last year, ICMR had organized four workshops on antimicrobial stewardship training, including one in partnership with Pfizer, for healthcare staff of various medical colleges and hospitals.


    ICMR-Pfizer AMR Centre has been funded by funds provided by Pfizer as part of its Corporate Social Responsibility (CSR) allocations under existing ICMR-Pfizer memorandum of understanding.


    Affirmation to this came by Dr Kamini Walia," Pfizer came forward on its own and offered its CSR funds with no strings attached,” Dr Kamini Walia, programme officer for AMR in ICMR, told TOI.


    She also confirmed that it was not the scarcity of funds for the AMR project which made ICMR collaborate with Pfizer.


    Medical Dialogues had earlier reported that Pfizer has provided an initial grant of Rs 6.97 crore for this initiative with a provision to scale up further as the program expands.


    Also Read: ICMR, Pfizer to work on antimicrobial resistance


    However, according to a report by the daily, the programme officer for AMR in ICMR accepted that there was no selection procedure by which ICMR decided to partner with Pfizer from among dozens of Indian and multinational pharma companies that manufacture antibiotics.


    "Pfizer's role is in the communication campaign, which they are more equipped to handle. They are making radio jingles and so on for which they have hired a creative agency. They have retained Rs 2-3 crore of the funds they offered for developing the communication material. But all the communication material is approved by ICMR. The rest of the money, Rs 4.47 crore, has been transferred to the ICMR," Dr Walia explained the daily.


    Speaking to the daily, Pfizer’s spokesperson said that its collaboration with ICMR is a CSR initiative formalized in 2017 and added that this was not aimed at promoting any Pfizer product. At Pfizer, ethical marketing takes priority over achieving commercial goals and it does not support or accept unethical promotion, the spokesperson insisted.


    "The ICMR-Pfizer collaboration will lead to serious Conflicts of interest(COI), with a significant potential for the academic and surveillance activities of ICMR to be influenced by the collaborating pharmaceutical firm. Such an influence will have a negative impact on the AMR policymaking process and derail our National AMR action plan implementation," Dr Abdul Ghafur, the technical advisory member for the National Antibiotic Policy, in a letter sent to the current DG of ICMR, Dr Balram Bhargava stated.


    Dr Ghafur requested ICMR to halt the partnership with Pfizer and explore Public Private Partnership with funding to a common pool as recommended by WHO. He also demanded that all members of the ICMR-AMR committee and similar committees of the National Centre for Disease Control (NCDC), the nodal agency for AMR in India, and others involved in surveillance and educational activities of the network must disclose their conflicts of interest in the WHO declaration format.


    The Alliance against Conflict of Interest has also urged ICMR DG through a letter to dissolve the partnership. "Pfizer being one of the leading manufacturer marketing antibiotics and vaccines in India has its primary interest in making more profit for its shareholders, while, ICMR is the premier public institute with primary responsibility to guide and regulate research including research on drugs and vaccines. Therefore, ICMR-Pfizer collaboration is an institutional Conflicts of Interest (COI)," stated the Alliance quotes TOI.


    Also Read: ICMR in collaboration with Zydus Cadila launches diagnostic kits to detect livestock diseases

    AMR projectanti-microbial resistanceantibioticantibioticsAntimicrobialCOIConflict of Interestdistrict hospitaldoctorsICMRICMR collaborationICMR pfizerICMR pfizer tieupIndian Council of Medical ResearchNational Centre for Disease Controlnursing homePfizerPPPpublic private partnershipWHOWorld Health Organisation
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok